April 14, 2017 — Shanghai, China
Event: Pharma China Annual Forum 2017
Presentation: China Commercial Excellence: Experiences From International Pharmas
China’s healthcare market continues to be an attractive one, growing at above GDP rates of 13% per annum, adding over US$300 billion by 2020. While the China market remains robust, pharmas are undoubtedly facing headwinds. Government regulations continue to change, causing uncertainties and often delays in product registration, downward pricing pressures, and market access hurdles. Competitors are moving up the value chain with highly competitive products that are alternatives to those from multinationals, and often can be more creative in their commercial approach.
One key aspect of maintaining both top-line and bottom-line growth in the face of these headwinds is a focus on operational streamlining. By improving both sales productivity and operational effectiveness, more of the company’s energy can be directed externally to the market and enhance China’s overall performance. Helen Chen from L.E.K. Consulting will present an overview of the opportunities and challenges facing pharmas in today’s environment, including how business leaders are approaching their China operations and the initiatives they are taking to ensure sustainable growth in this second largest global market.
Date/Location: Friday, April 14, 2017
Le Royal Meridien
Shanghai, China
Time: 11:45 am – 12:15 pm
Helen Chen:
Helen Chen is a Managing Director and Partner at L.E.K. Consulting and serves as the Head of L.E.K.’s China practice in Shanghai. Helen is also head of L.E.K.’s China Biopharmaceuticals & Life Sciences practice and has extensive case work and industry experience covering the full biopharmaceutical and medical devices value chain. Helen has more than 25 years of consulting and industry experience in the U.S. and Asia markets and has resided in China since 2000. She helps companies expand their presence in China and leverages China’s resources to improve their global businesses. She is a frequent speaker and author on the opportunities and issues in China’s Healthcare and Life Sciences sectors. Prior to joining L.E.K., Helen held senior management roles at a number of technology companies in the U.S. and China. She was an associate director of finance at Genentech and a sales planner at Abbott Laboratories. Helen has an honors degree in Applied Mathematics from Harvard University.
About Pharma China Annual Forum 2017
The Pharma China Annual Forum 2017 is an English language annual pharma industry event oriented for foreign drug companies in China. It is sponsored by RDPAC and WiCON International Group LLC, the publisher of WiCON|Pharma China. The event's emphasis is on healthcare policies, drug regulations, market access and strategic issues as well as potential impacts of latest and upcoming policy changes on the Chinese pharma industry. In addition, contemporary trends of M&As, R&D and licensing, business hotspots and e-commerce, as well as future market outlook will be explored and discussed.
About L.E.K. Consulting
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. Founded more than 30 years ago, L.E.K. employs more than 1,200 professionals across the Americas, Asia-Pacific and Europe. For more information, go to www.lek.com.